![Multiple parameters shape the 3D chromatin structure of single nuclei at the doc locus in Drosophila | Nature Communications Multiple parameters shape the 3D chromatin structure of single nuclei at the doc locus in Drosophila | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-32973-y/MediaObjects/41467_2022_32973_Fig1_HTML.png)
Multiple parameters shape the 3D chromatin structure of single nuclei at the doc locus in Drosophila | Nature Communications
![How Dare They Peep into My Private Life?”: Children's Rights Violations by Governments that Endorsed Online Learning During the Covid-19 Pandemic | HRW How Dare They Peep into My Private Life?”: Children's Rights Violations by Governments that Endorsed Online Learning During the Covid-19 Pandemic | HRW](https://www.hrw.org/sites/default/files/styles/16x9_medium/public/media_2022/05/202205crd_edtech_illustration.jpg?h=ea95bb15&itok=xBt1pnUI)
How Dare They Peep into My Private Life?”: Children's Rights Violations by Governments that Endorsed Online Learning During the Covid-19 Pandemic | HRW
![Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study - The Lancet Rheumatology Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study - The Lancet Rheumatology](https://www.thelancet.com/cms/asset/3ebd0253-5fcf-4189-af5a-96dca7f46a78/gr1.jpg)
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study - The Lancet Rheumatology
![SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22905-7/MediaObjects/41467_2021_22905_Fig1_HTML.png)
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications
![Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial - The Lancet Infectious Diseases Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/79907246-571c-4f11-a6f3-6edc308e58c1/gr1.jpg)
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial - The Lancet Infectious Diseases
![Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning | Nature Communications Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-30545-8/MediaObjects/41467_2022_30545_Fig1_HTML.png)